A Phase I, Randomized, Single-Dose Study Evaluating the Biosimilarity of TAB008 to Bevacizumab in Healthy Volunteers
2018 ◽
Vol 36
(15_suppl)
◽
pp. e14504-e14504
2011 ◽
Vol 69
(1)
◽
pp. 221-227
◽
2008 ◽
Vol 26
(15_suppl)
◽
pp. 14019-14019
1989 ◽
Vol 29
(5)
◽
pp. 457-462
◽
Keyword(s):